Sponsored Testing Programs

A Solution to Drive Launch Effectiveness

A collaborative and integrated approach to maximize your product launch success. Through the NeoGenomics’ Sponsored Testing Program (STP), we can help broaden your voice and amplify reach and frequency to pathologists and oncologists to build awareness and accelerate biomarker testing. An STP removes testing barriers and uses real-time data to identify the right patient at the right time for the right treatment. Sponsored Testing Programs are available for both companion diagnostics and genomic testing. If you would like to learn more about day one readiness campaigns and building out a clinical diagnostic strategy, please email our Vice President of Business Development, Ashi Malekafzali, to schedule a consultative discussion.

Collaborate Clinical icon
Immediate access to a broad network of Pathologists
Stethoscope Clinical icon
Raise biomarker awareness
Patient Clinical icon
Identify eligible patients for treatment
Regulated Seq Clinical icon
Drive launch success

On-going Sponsored Testing Programs

While third parties and other commercial organizations (“third parties”) may provide financial support for any STP, testing and services are performed by NeoGenomics. Healthcare professionals must confirm that patients meet certain criteria to qualify for an STP. Third parties may receive de-identified patient data from this program, but at no time would they receive patient identifiable information. Additionally, third parties may receive contact information for healthcare professionals who use this program. Neither healthcare professionals nor participating patients in any sponsored testing program have any obligation to recommend, purchase, order, prescribe, promote, administer, use or support any other products or services from NeoGenomics or from third parties.

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients